Recombinomics | Elegant Evolution






Home Founder What's New In The News Consulting





























H1N1 Consulting

Paradigm Shift

Viral Evolution

Intervention Monitoring

Vaccine Screening

Vaccine Development

Expression Profiling

Drug Discovery

Custom Therapies

Patents



Audio:Apr15 May20 Jun17 Jul15 RSS Feed twitter News Now                         
Live feed of underlying pandemic map data here
Commentary


H1N1 D225G Transmission In Singapore
Recombinomics Commentary 16:54
July 26, 2010

Recently released sequences from Singapore support transmission of D225G.  One isolate, A/Singapore/SS003/2010 was from a fatal case (45M), while the other, A/Singapore/SS004/2010 was from an ICU case (37M).  Both were collected in April, 2010, and the sequential sample numbers raise the possibility that the two patients were contacts/relatives.  Sharing of additional polymorphisms by the two sequences supports human to human transmission. 

Recent sequences (collected June 30, 2010) from Nanjing, China also support transmission of D225G and raise concerns this polymorphism is become more common and more easily transmitted.  HA with D225G can bind to 2,3 receptors which are found on human lung cells, which may lead to increased concentrations of H1N1 in lung and an unfavorable outcome, as seen in severe and fatal cases.

The emergence of D225G In the current season was anticipated as more of the human population develops immunity to wild type sequences.  Mill Hill has designated a Ukraine sequence with D225G as a “low reactor”, which supports the emergence of D225G.  In China, D225G was found in association with G158E, another marker linked to low reactors.
Recent reports from India have described an increase in H1N1 cases as well as an increase in severe or fatal cases.  Earlier sequences from India had D225G, raising concerns that levels of this marker are on the rise in India also.

WHO has maintained that D225G did not transmit, based on a lack of clustering in time and space.  However, the recent sequences from Singapore and Nanjing, China show such clustering, as did prior sequences from Ukraine and Russia.

A revised WHO and CDC “working hypothesis” on D225G is long overdue.

Media Links

Recombinomics Presentations

Recombinomics Publications

Recombinomics Paper at Nature Precedings
















Home | Founder | What's New | In The News | Contact Us

Webmaster: webmaster@recombinomics.com
© 2010 Recombinomics.  All rights reserved.